Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...

In the insurance segment, Cigna is a major commercial coverage provider with 16.1 million members as of Dec. 31. Humana had fewer than 600,000 commercial customers and is withdrawing from employer ...

Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...

Cigna is mainly a commercial health insurer, while Humana is mainly about Medicare Advantage. It helps that Cigna announced a deal in January to sell its Medicare Advantage business for about $3.7 ...

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

Cigna and Humana are reportedly in talks about a possible merger, nearly a year after a similar deal fell through.

Humana's Future Requires a MA Alternative Over recent years, Humana has phased out its commercial and non-Medicare plans, focusing more on Medicare Part D and Medicare Advantage plans. Its total ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on HUM stock, giving a Buy rating yesterday. Ann Hynes has given her ...

Humana’s earnings beat Wall Street expectations, but the insurer said 2025 results might come in lower than analysts project, as it works to bolster its core Medicare business. The company’s shares we ...

HUM's Q3 results are likely to suffer from decline in commercial fully-insured premiums and higher operating costs, partly ...

Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2024 (3Q24 ...

the early talks about the merger would significantly expand Cigna’s footprint in Medicare Advantage alongside its commercial insurance prowess while leveraging Humana’s strong Medicare segment.